Risultati della ricerca - Heinz‐Josef Lenz

Raffina i risultati
  1. 1
    Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer

    Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer di Thomas Winder, Heinz‐Josef Lenz

    Pubblicazione 2010
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Safely targeting cancer stem cells via selective catenin coactivator antagonism

    Safely targeting cancer stem cells via selective catenin coactivator antagonism di Heinz‐Josef Lenz, Michaël Kahn

    Pubblicazione 2014
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    Explaining the Unexplainable: EGFR Antibodies in Colorectal Cancer

    Explaining the Unexplainable: EGFR Antibodies in Colorectal Cancer di Axel Grothey, Heinz‐Josef Lenz

    Pubblicazione 2012
    Testo Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  4. 4
    Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor

    Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor di Ana Sebio, Heinz‐Josef Lenz

    Pubblicazione 2015
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Biomarker in Colorectal Cancer

    Biomarker in Colorectal Cancer di Marta Schirripa, Heinz‐Josef Lenz

    Pubblicazione 2016
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  6. 6
    Chemotherapy with Targeted Agents for the Treatment of Metastatic Colorectal Cancer

    Chemotherapy with Targeted Agents for the Treatment of Metastatic Colorectal Cancer di Claus‐Henning Köhne, Heinz‐Josef Lenz

    Pubblicazione 2009
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  7. 7
    TAS-102, a novel antitumor agent: A review of the mechanism of action

    TAS-102, a novel antitumor agent: A review of the mechanism of action di Heinz‐Josef Lenz, Sebastian Stintzing, Fotios Loupakis

    Pubblicazione 2015
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  8. 8
    The potential of targeting Wnt/β-catenin in colon cancer

    The potential of targeting Wnt/β-catenin in colon cancer di Ana Sebio, Michaël Kahn, Heinz‐Josef Lenz

    Pubblicazione 2014
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  9. 9
    Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions

    Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions di Francesca Battaglin, Madiha Naseem, Alberto Puccini, Heinz‐Josef Lenz

    Pubblicazione 2018
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  10. 10
    Comparative effectiveness of screening strategies for colorectal cancer

    Comparative effectiveness of screening strategies for colorectal cancer di Afsaneh Barzi, Heinz‐Josef Lenz, David I. Quinn, Sarmad Sadeghi

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Molecular Pathways: Estrogen Pathway in Colorectal Cancer

    Molecular Pathways: Estrogen Pathway in Colorectal Cancer di Afsaneh Barzi, Annika Lenz, Melissa J. LaBonte, Heinz‐Josef Lenz

    Pubblicazione 2013
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  12. 12
    Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes

    Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes di Sebastian Stintzing, Sabine Tejpar, Peter Gibbs, Lars Thiebach, Heinz‐Josef Lenz

    Pubblicazione 2017
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  13. 13
    Molecular Pathways: Cachexia Signaling—A Targeted Approach to Cancer Treatment

    Molecular Pathways: Cachexia Signaling—A Targeted Approach to Cancer Treatment di Yuji Miyamoto, Diana L. Hanna, Wu Zhang, Hideo Baba, Heinz‐Josef Lenz

    Pubblicazione 2016
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  14. 14
    Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity

    Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity di Qinqin Cheng, Xiaojing Shi, Menglu Han, Goar Smbatyan, Heinz‐Josef Lenz, Yong Zhang

    Pubblicazione 2018
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies

    Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies di Alberto Puccini, Francesca Battaglin, Maria Laura Iaia, Heinz‐Josef Lenz, Mohamed E. Salem

    Pubblicazione 2020
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  16. 16
    All You Need to Know About <i>DPYD</i> Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly Guide

    All You Need to Know About <i>DPYD</i> Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly Guide di Federico Innocenti, Sarah Mills, Hanna K. Sanoff, Joseph Ciccolini, Heinz‐Josef Lenz, G. Milano

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes

    Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes di Qinqin Cheng, Zhefu Dai, Goar Smbatyan, Alan L. Epstein, Heinz‐Josef Lenz, Yong Zhang

    Pubblicazione 2022
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement

    Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement di Roderich E. Schwarz, Jordan Berlin, Heinz Josef Lenz, Bernard Nordlinger, Laura Rubbia‐Brandt, Michael A. Choti

    Pubblicazione 2012
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Inhibition of dUTPase Induces Synthetic Lethality with Thymidylate Synthase–Targeted Therapies in Non–Small Cell Lung Cancer

    Inhibition of dUTPase Induces Synthetic Lethality with Thymidylate Synthase–Targeted Therapies in Non–Small Cell Lung Cancer di Peter M. Wilson, Melissa J. LaBonte, Heinz‐Josef Lenz, Philip C. Mack, Robert D. Ladner

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Molecular insight of regorafenib treatment for colorectal cancer

    Molecular insight of regorafenib treatment for colorectal cancer di Hiroyuki Arai, Francesca Battaglin, Jingyuan Wang, Jae Ho Lo, Shivani Soni, Wu Zhang, Heinz‐Josef Lenz

    Pubblicazione 2019
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: